Critical

GHB/GBL intoxication and withdrawal

GHB/GBL · Psychiatry / Behavioural
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Gamma-hydroxybutyrate (GHB) and its prodrug GBL cause rapid-onset deep coma with abrupt recovery, often with a narrow margin between euphoria and respiratory arrest. Dependence produces a severe, benzodiazepine-resistant withdrawal syndrome resembling delirium tremens. Both are medical emergencies.

Red flags

  • Respiratory depression or apnoea (overdose)
  • GCS not improving as expected (suspect co-ingestant or other cause)
  • Autonomic instability, hyperthermia or seizures (withdrawal)
  • Delirium progressing despite benzodiazepines
  • Aspiration or airway compromise

Assessment

Differential diagnosis

  • Other sedative overdose (alcohol, benzodiazepines, opioids)
  • Organic coma (hypoglycaemia, head injury, post-ictal, intracranial event)
  • Mixed-drug intoxication (common in chemsex settings)
  • Alcohol or benzodiazepine withdrawal (for the withdrawal picture)
  • Sepsis or metabolic encephalopathy

Investigations

  • Capillary glucose, GCS and continuous observations
  • ABG/VBG and capnography (hypoventilation)
  • ECG and cardiac monitoring
  • Bloods: U&E, FBC, CK, glucose; toxicology and alcohol/paracetamol
  • CT head if coma not explained or focal signs

Management

  • Support airway and breathing — position, oxygen, monitor SpO2 and CO2; intubate if unable to protect airway
  • Avoid naloxone/flumazenil as diagnostic (ineffective for GHB, may precipitate problems)
  • Observe closely — GHB coma typically resolves abruptly within 2-6 hours
  • Screen for co-ingestants (opioids, stimulants) in chemsex presentations
  • For withdrawal: recognise early (anxiety, tremor, tachycardia, autonomic instability progressing to delirium/seizures)
  • Treat withdrawal with high-dose benzodiazepines, escalating as needed; consider baclofen
  • Use critical care for severe/refractory withdrawal (may need barbiturates/propofol)
  • Offer substance-misuse referral and safeguarding assessment

Drugs & doses

Oxygen — high-flow via non-rebreathe mask; support ventilation as needed
Diazepam — 10-20 mg PO/IV repeated for withdrawal, titrated to control (large doses often required)
Lorazepam — 2-4 mg IV for agitation/seizures in withdrawal
Baclofen — 10 mg PO TDS as adjunct in GHB withdrawal
Phenobarbital / propofol — in ICU for benzodiazepine-resistant withdrawal

Disposition

Observe overdose until fully recovered and screen for co-ingestants; admit withdrawal to a monitored/critical-care bed for aggressive benzodiazepine treatment, with substance-misuse and safeguarding referral at discharge.

Complications & pitfalls

  • Respiratory arrest and aspiration (overdose)
  • Rhabdomyolysis
  • Benzodiazepine-resistant withdrawal delirium and seizures
  • Cardiovascular instability
  • Death from either overdose or untreated withdrawal

Exam pearls

  • GHB has a very steep dose-response — recreational and lethal doses are close
  • Coma is deep but typically short and self-limiting; supportive airway care is the mainstay
  • Withdrawal can be more dangerous than overdose and is benzodiazepine-resistant — use high doses early
  • Suspect GHB in sudden deep coma with rapid spontaneous recovery, especially in chemsex contexts
  • Always consider co-ingested drugs and safeguarding/exploitation issues

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.